Human TGF-beta Type II Receptor

TGFBR type II receptors (TGFBR2) are transmembrane tyrosine kinases or associated with cytoplasmic tyrosine kinases** related to resistance to TGF-beta inhibition of cell proliferation and trap TGF-beta I from access to wild-type receptors, the growth-inhibitory and proapoptotic activities of the cytokine, human chromosome 3p22-p21: [§§; †, ‡]. A cysteine-rich wildtypeº SNP-(ancestral C-509T-allele and G-875A variant in TGFBR2) transition (exon 4) not an active mutation in the (constitutional) cDNA extracellular domain transmembrane (ECM) receptors cyclin-dependent kinases (cdks)º also bindsº to TGFBR2. ACVR2 (activin) a GS domain** member of the type II  receptor family ligand-binding domain and TGFBR type II* receptor, and mutations in exon 3 the polyadenine tract (BAT-RII, replication error-RER(+) in exons 4 phenotype, and 10-ACRV2* have premature termination codons (PTCs)-mRNAs can be regulated by miRNAs (endogenous non-coding RNAs) this is a use for inhibitors that can target,  PTC siRNA the effect could silence proteins using any C-terminal such as the gene promotor 5'UTR, mainly in the 3'UTR of mRNA) »» alter the response relative to TGF-beta (a multimer) that inhibits epithelial cell growth, however TGF-beta2 differs in that it binds the TGF-betaR-II isoform restricted to cells of bone-marrow (EC 'vectors') endothelial cells; induction of growth inhibition «« (Morin (flavonol), mannosidase and an molecular Bortezomib PTK/STK characterisation of TβRI suggest a novel mechanism an etoposide Epigallocatechin E.gallate provided by a (G)8, by reaction provides an unusual, C/T allele PKC interaction (autophosphorylation)** that is better able than wild-typeº to induce a the dual kinase cytoplasmic domain specificity soluble betaglycan the type III receptor acts as potent type IIº inhibitor) and the loss of trans-phosphorylation or constitutive activation of TGF-beta1 mediated (homozygous and heterozygous polymorphism (heteroduplexes)» functionally related tentative (MMP) involvement of «three major systems as the Marfan syndrome type II gene) growth control or hypophosphorylation.  The functional inactivation of the Germline (Adenoviral -mediated soluble vectors bind and transform cells similar to RB protein retinoblastoma)-gene product (a dominant negatively acting mutant TbetaRIIDN) regulated by TGFBR type II receptors polyadenine (A)(10) tract  can result in microsatellite instability (MSI) of the microsatellite mutator phenotype (MMP) as RER(+), for 'replication errors' exhibiting, somatic type I receptor hereditary mutations ETS transcription factors (Ewing sarcoma EWS and related peripheral primitive tumors, mononucleotide (MSI-H microsatellite instability-high) hereditary TGFBR2 and BAX (G)8 mononucleotide mutation guanine/adenine (G/A) with cytosine/thymine 'C/T' colon tumors) a putative tumor suppressor gene mutations, epithelial-mesenchymal transition (EMT). ETS supression requires functional TGFBR2, truncated type II receptors dominant-negative mutants that selectively block type II receptor signaling to TGF-beta induction (cell proliferation and differentiation and type I receptors ECM production) by inducing the escape of cells from TGF-beta-mediated growth control in the TGFBR2 gene characterized by germline plus induces secondary somatic mutations. Once the presence of TGFBR2 mutator mechanisms for germline mutations are generated, links (soluble vectors) have a Elf3 'C-terminal' DNA-binding ETS-related domain retroviral (CAT)-construct expressing microsatellite instability (MSI) related to DNA-mismatch repair (MMR proficient and deficiencies) sequences of « Three''' specific small interfering RNAs (siRNAs)''' mono-, di-, and tri-nucleotide repeat hypermutable sequences targets many mRNAs mainly in the 3'UTR''' of mRNA at the poly(A)(10) tract MMR (MRC-1) deficiency, results in intestinal epithelial defects of genes known to be mutated, deoxycytidine (DCK) restores TGF-beta type II receptor (MMR 'initiated' Apc mutation) in many cancer cell lines.

Abeta peptide (APP)-cleaving enzyme (BACE) is a transmembrane aspartyl protease

Alzheimer disease amyloid protein, Amyloid beta A4 protein, Protease nexin-II
PDB Structure THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE (RESIDUES 1-40) 1AML

The beta-amyloid protein A4 (APP amyloid beta (A4) precursor protein Protease nexin-II ) is derived from a larger protein used for the major protein subunit APP A4 polypeptide Alpha-secretase locus: 21q21: [§§] generates soluble amyloid protein and occurs in the interior. CAA (Cerebral amyloid angiopathy) that results from deposition of beta-amyloid peptide. The study of this disease goes back about hundred years ago to one of the pioneers of the study Oskar Fischer. Neuroserpin (Serpini1) is a neuroprotective component of amyloid plaques, A68 (SERPINA3) may interact with beta A4, ubiquitin involved in protein transport to and from the trans-Golgi network, of endoplasmic reticulum (ER)-associated which may be initiated by insulin-degrading enzyme IDE-generated degradation. Thereby precluding formation and deposition of beta-referred to as beta/A4 and gamma-secretases generated APP components with amyloidogenic features (amyloid plaques, neurofibrillary tangles) progressive cerebral deposition of extracellular filaments the elongation phase of amyloid fibril formation, preventing them from participating in redox cycling with other ligands. Resulting in cell surface delivery of amyloid beta peptide formation and neurotoxicity (AChE) - acetylcholinesterase (Yt blood group) colocalizes with Abeta deposits of brains in AD patients the brain [Brp1] proteoma generation of Abeta involves and accelerates assembly of mutations, homologous to related 5'-UTR of the light and and heavy ferritin genes also the presence of an Iron-Responsive Element (IRE) whereas beta- and gamma-secretases cleave on the N- and C-terminal ends respectively; within Abeta peptide (APP)-cleaving enzyme (BACE) is a transmembrane aspartyl protease* in the brains of transgenic Tg2576 mice in neuritic plaques a high titer of anti-Abeta42 antibodies may protect humans from AD. Some toxic effects are due to other mechanisms (amyloid precursor-like protein-APLP1, A4) as well as in the ultimate apoptotic death localized to multivesicular bodies of neurons at or near the synapse. Processing of APP occurred in the compartment, PLD1 regulates intracellular trafficking, centered within the transmembrane domain transported by kinesin-I. KAI1 was activated by a ternary complex the presenilin-dependent (PSEN1) C-terminal cleavage product that alters proteolytic processing of the synuclein, alpha (non A4 component of amyloid precursor) and amyloid precursor protein (APP) and interactions with X11 proteins APBA1-2 (FE65L1, and FE65L2 amyloid beta (A4) precursor protein-binding, family A, member 1) regulates APP metabolism, dependent on the acetyltransferase activity of TIP60, presenilins (PS1) causal genes are components of gamma-secretase. Nicotine may play an important role in APP secretion and protection against toxicity induced by APP metabolic fragments (beta-amyloid [Abeta], ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. BACE1 - beta-site APP-cleaving enzyme 1 inhibits in vitro processing of peptide and APP substrates and may be useful for monitoring the effects of drug candidates, A2M - alpha-2-macroglobulin has been implicated biochemically in binding and degradation of the amyloid beta (Abeta) to which alpha-synuclein/NAC precursor, is tightly associated. Phosphorylated C-gamma may accumulate at the splicing factor compartment where ApoE-Abeta interaction is critical implications for both Alzheimer's and prion diseases for progress towards (LRP) low density lipoprotein receptor-related protein that BACE1 can efficiently cleave affects are as a functional linker to pre-mRNA. Splicing is regulated by Fe65 and FE65 a 'brain-enriched protein' that binds to APP phosphorylation, fragments are reciprocally involved in the regulation of FE65-dependent gene transactivation not greater than those observed.

Notch1 can trans-activate an APP target gene, Kai1, and vice versa.

CD82 molecule, KAI1, Metastasis suppressor Kangai-1
PDB Structure KAI1 was modeled based on crystal structure of the extracellular domain of tetraspanin protein member, CD81 1G8Q

KAI1 cell-surface glycoprotein and the molecular mechanisms underlying the TIP60 coactivator complexes for the metastasis suppressor gene NGF reverts by the expression of the, KAI1: for 'kang ai' (抗癌 Chinese for anticancer) locus: 11p11.2; [§§] is a members of the Transmembrane 4 superfamily (TM4SF), are likely to be a selective downregulation strategy for many genes it is an 'activation antigen' of T cells at the level of transcription or posttranscription is down-regulated in the progression of common solid epithelial tumors that leads to the down-regulation of the KAI1 gene. KAI1 is the human homolog of the mouse leukocyte surface antigen R2. DARC is essential for the function of CD82 antigen KAI1, CD82 specifically suppresses tumor metastasis of antigen R2, CD82 (KIA), is incorporated into the viral envelope, gp78 [AMFR-autocrine motility factor receptor] associates with KAI1 (also known as CD82) involved in ER-associated (endoplasmic reticulum) degradation (ERAD), calnexin (CANX) may play a role in this process. Notch1 can trans-activate an APP target gene, Kai1, and vice versa. Tetraspanin-enriched microdomains is important for KAI1/CD82's motility-inhibitory activity are glycoproteins of unknown function, and is directly associated with the EGF receptor (EGFR). KAI1 was modeled based on crystal structure of the extracellular domain of tetraspanin protein member, CD81 and two other tetraspans, CD9-(MRP-1) and CD19. DARC - Duffy blood group, chemokine receptor (Homo sapiens) is essential for the function of CD82, early B cell marker CD9 a molecular partner (CD9P-1) and CD151 (Raph blood group) was found to be coupled. CD151 and CO-029 (TSPAN8 tetraspanin 8) are supposed to promote metastasis formation. KISS1 triggers dormancy in solitary, metastatic tumor cells. COOH-terminal interacting tetraspanin (KITENIN)-vang-like 1 (van gogh, Drosophila) by interacting with KAI1 participates in the regulation of the tumor formation as well as increased invasiveness and cells. Adhesion forces laterally organize cellular membranes via the presence vs absence of, inversely associated univariate and multivariate, Laminin (LN)- or (FN) fibronectin, associations that usually occur in the context of "tetraspanin web"; its mechanism of action has not yet been fully elucidated.

Pol I-specific factor SL1

SL1 (Transcription initiation factor SL1/TIF-IB subunit C, RNA polymerase I-specific (species-specific)TBP-associated factor 110 kDa mediated TAF(I)110, SL1) is required for RNA polymerase I to synthesize ribosomal RNA of all 3 TAF1 proteins (TAF1A stromelysin-1: [§§], TAF1B: [§§] and TAF1C: [§§]) mutually exclusive binding to TBP excludeing TFIID binding selectivity factor of the RNA polymerase II locus: 1q42, 2p25 and 16q24 termed sulfolipid-1 (TAF1C-SL1). c-Myc and p53 binds to and associates with the Pol I-specific factor SL1 immature dimeric viral RNA palindrome one of the five most frequently mutated TAF(I)68 associated with PCNXL2 and a critical mechanistic link Runx2 complex containing RNA Pol I transcription factors UBF1 and SL1 that affects the rDNA promoter, PCAF acetylates TAF(I)68. The viral human rRNA promoter contains two factor upstream cis-control sequences, the core and upstream control element (UCE), SL1 and SL2 are not functionally equivalent.

A reverse process ET-1 endothelin-ecadotril receptor subtypes synergised RB-101/NEP 24.11 Endothelin-converting enzyme tyrosine hydroxylase loop.

Three isoforms of human endothelin have identified peptides individual endothelial cells can secrete produced by vascular endothelial cells contractive and adhesive properties is a potent vasoconstrictor with various pharmacological responses, locus: 6p24-p23: [§§]. Three isoforms of human endothelin (ET)-1, -2, -3 and the endothelin receptors (EDNR) its Endothelin-converting enzyme receptor as four separate isoforms, a metalloprotease is essential for generation of the biological effects of endothelin-1. Only by the bacterium through multiple proteolytic steps as a prepro-ET1 mRNA was observed in placental vascular smooth muscle cells (PVSMCs) on ET-1 release and preproET-1 mRNA-PPET-1 (in the case of GATA-1) corresponding cDNA and determined the presence of neutral endopeptidase (NEP) in human endometrium during the menstrual cycle in the human decidualized endometrial cells. Endothelin-1 is a pain mediator it can coincidentally produce analgesia through endothelin-B receptors (EDNR). A neutral phosphoramidon-sensitive metalloproteinase contribution of the metalloproteases, neutral endopeptidase (^: NEP/MME-membrane metallo-endopeptidase, use of dual inhibitors complicates results cross-communicated it is mainly degraded with Neutral endopeptidase 24.11) and the endothelin along with its receptors ET-A/ET-B receptor, antagonist bosentan as well as by specific inhibition of either ET(A)R, ET(B)R given to ACE inhibitors (In the ramipril group receptor blockade with BQ-123 (t did not affect the response to SNP-sodium nitroprusside) and BQ-788, a mixed ETA/ETB receptor antagonist bosentan.) which can reverse process ET-1 (endothelin-) ecadotril in a second declining gradient required for the androgen increase beta adrenergic receptors potentiated paclitaxel-induced apoptosis blocked the antiapoptotic effect of ET-1 although dopamine is a catecholamine that selectively inhibits the response to mu opioid receptor (MOR). Phenylalanine stimulates sensitive-MMP-2 metalloproteinase inhibitor GM6001 can be reproduced with ECE inhibitors these opioid receptor subtypes causes RB-101 to be strongly synergistic (required for eicosanoid sensitivity) or can cross-communicate with Neutral endopeptidase 24.11, and is not inhibited by other E-24.11 inhibitors, transferred to clinical medicine_in adult human brain microvascular endothelial cells (HBMECs). CHGA-chromogranin A (parathyroid secretory protein 1) that correlated positively with reverse process ET-1 via activation of HIF-1 alpha, independent of hypoxia that placental grouth factor (PlGF)-induced for ET-1 and tyrosine hydroxylase (TH) expression in monocytes creates a loop. Share a similar core structure to the thermolysin N-terminal domain Endothelin-converting enzyme (ECE)-1 termed 'neutral' responsible for production of vasoactive endothelin is a peptide hormone mediated by binding to endothelin type A (ETA-(hETAR)) and endothelin type B (ETB) receptors.

footnote

Candoxatrilat Neutral endopeptidase inhibitors such as Candoxatril have a dual mechanism of action. [↩]

Talin in a low-affinity state as a structural link to Ezrin four point-one band protein 4.1 cytoplasm domain

Interactions between the (seven-helical bundle domain (Vh1)) and vinculin (193065*), talin, and actin filaments appear to constitute a slippage interface, mechanical forces which binds to integrins and actin filaments, in vitro a molecular slip bond with varying degrees of correlated motions with actin filaments through focal adhesions generating a molecular clutch. And in the talin-vinculin system, molecular mechanotransduction cell-ECM (extracellular matrix) forces can occur synergistically. Cell transformation by viruses » disrupts the normal organization of talin detected in 'doughnut-shaped' » aggregates radiating tangentially from a «« central ellipse or circle produces inhibitory »»»phagocytosis of (MARCKS) activity against neurite outgrowth or invasiveness. Linked to the cytoplasmic face of integrins in cell-ECM junctions of cell-cell adhesion molecules of the cadherin family that associates with beta-catenin, lymph node high endothelial venules (HEV*) which is localized at cadherin-based cell-cell adherens junctions. This portion (alpha-actinin and vinculin) of the cytoplasmic head domain (Vh) in beta(1) wild-type cells through the beta(1) integrin cytoplasmic tail (Vt) this gene, reduced deposition has been associated with fibronectin that is significantly overexpressed in some cancers (From »»»anaphase to telophase (assembly/disassembly), talin is present in the cleavage furrow, and what little is present relocates to the undersurface.) a cell surface receptor required for cell-substratum adhesion at the ruffling edges of the cells, cell-substratum contact, is on band 3, supporting the contention that the other is containing bands 1 plus 2 according to their differential requirements «««three distinct phases this promoter accounts for most of the talin 2, to reveal beta(1) integrin and beta3 mutation tail-tail interactions. Talin contains two integrin binding sites, one in the homologous and another near its C terminus cytoplasmic domains. And is not, the talin FERM four point-one ezrin radixin moesin domain (ets-related molecule ETV5) domain, necessary for proper localization of L-selectin¤ on the cell surface (LFA-1-integrin, beta 2), from the basal cell surface and accumulation underneath ^[º^] the cell surface of the integrins within the cell export signal, defines a mechanism for spatial generation strengthened by PtdIns(4,5)P(2), cell spreading depends on integrins and organization of focal adhesions links. The intracellular domains of the fibronectin receptor alpha5beta1¤ auto-phosphorylation Phosphatidylinositol-4,5-bisphosphate (PIP2) must be localized to specific sub-cellular sites canonical (PTB) phosphotyrosine-binding domains near its C terminus cytoplasmic domains in the cytoskeletal-associated proteins band 4.1, ezrin, and talin that direct their association with the N-terminal segment, by integrins in cell adhesion activated the focal adhesion kinase-FAK/Src complex » autophosphorylation » that can transduce biochemical signals to the « cell interior to the cytoskeleton¤. The band 4.1† domain was first identified in the red blood cell protein, band 4.1/JEF (JAK, ERM, FAK) include plant kinesin-like calmodulin-binding proteins (KCBP) with similarity to protein 4.1 is the prototype of a family. Proteins that have been postulated to serve as structural links between the plasma membrane and the cytoskeleton. The N-terminal region of the 'microvillar core' origin to the inner leaflet; ‡ of the ventral plasma membrane homology within the stem villi (apparent on isolated ventral plasma membranes in the submembrane cortex) in the cortical cytoplasm reveals that this site is unique to ezrin and is common to the band 4.1-talin-ezrin protein family which diverged early during evolution†. Talin contains binding sites (VBS) that can bind three vinculin-binding site individually to the vinculin head (Vh) domain talin VBSs activate vinculin which displaces the vinculin tail (Vt) domain localized TLN (Talin-1) to human chromosome band 9p13; [§§], and promote firm adhesion to and migration across the endothelium. Talin through focal adhesions at sites of actin stress fibres and areas of cell-cell contact to a minor phospholipid component of cell membranes PI4,5P(2)-induced talin activation at early stages of adhesion and recruitment of proteins to the plasma membrane (PtdIns(4,5)P(2)) regulates interactions in a high-affinity state (in a process known as integrin activation or priming) after contacting a wounded vessel in vasculitic lesions between these proteins linked to the TLN gene locus 9p cytoplasmic face of integrins that in circulating platelets exist in a «««low-affinity state ((low, intermediate, and high) required for a functional immune system) and the expression of platelet prothrombinase activity response into the platelet cytosol in cell-ECM junctions.

footnote

Centrosomal protein, CPAP (centrosomal P4.1-associated protein), specifically forms a lattice beneath the membrane and accumulation underneath the cell surface within the cell export signal glycophorin C is squeezed out in the underlying network, and defines a mechanism linked to the Rh blood group the nonerythrocyte isoform of the cytoskeletal protein 4.1R (4.1R) red blood cell protein 4.1 detected.[º]

Tenascin-C mechanisms TEN(14) provisional matrix embryonic meshwork like adult structure

Extracellular matrix component tenascin C locus 9q33; [§§], is a class of ligand antiadhesive matrix present during organogenesis, development, and wound repair, upon surface binding. During embryonic development, but is absent from most normal adult tissues. TN (tenascin C) is reexpressed, however, resembling the wound healing matrix. These interactions take several forms (proangiogenic/antiangiogenic)angiogenesis in vitro and in vivo downregulation and upregulation that may be categorized as direct or indirect in growth and development, as well as in wound healing. Molecular features may allow neuronal synapses plasticity in its 5'-leader may function as a cis-acting regulatory signal by forming a molecular bridge (F11 coagulation factor XI (plasma thromboplastin antecedent)) in muscle and vascular remodeling or coronary vasculo/angiogenesis. Strongly dependent on cell adhesion in tendon anlagen, and in developing cartilage in the pericellular/territorial matrix to the 13th fibronectin type III unit (FNIII13) the small splice variant binding did not ( the possibilities that sulfated glycolipids may function as cellular receptors) inhibit adhesion (both adhesive and anti-adhesive properties) of heparan sulfate proteoglycans fibrils matrix interacting to form a meshwork-like structure (ECM) extracellular matrix protein. One such repeat, the 14th EGFL repeat Ten(14) assumes in two distinctly different conformations characterized by a change from a round, nonmigratory morphotype to an elongated, migratory morphotype. Expressed in a spatially and temporally restricted pattern in the pericellular/territorial matrix role in maintaining articular cartilage and possibly in cartilage repair uniquely regulated spatially. These interactions are mediated by the 'proteoglycan core frequently seen apposed to the fibrinogen globe', this the pericellular represents a mechanism for the invasive properties present on the surface of either neurons or glioma cells of the FNIII domain recombinant tenascin-C missing the C-terminal fibrinogen-like [FGL1] globe which did not bind to proteoglycans » specifically synthesized by neurons, while human natural killer 1 (HNK-1) « a epitope attaches to these molecules modifies adhesive properties. At least produced by radial glial profiles (adult newt) forming axonal compartments in which axons grew, changes are invariably accompanied by structural synaptic remodelling in the adult that continue to display "embryonic" features hypothalamo-neurohypophysial system or on each side of the brain (HNS) and undergo remodeling whenever the proper stimuli (oxytocin) intervene. The smaller tenascin-C isoform likely plays a structural and adhesive role. Hexabrachion is a large (tenascin C) glycoprotein, similar to those found in type III fibronectin are each encoded by a single exon also found elsewhere in the genome. Individual "matrikine" domains within have been described in its complex relationship with decorin and fibronectin in normal wound healing. Is a ligand for the lectins of these G3 variant proteoglycans isoforms (syndecan) that provide cartilage with its load bearing properties on the tenascin molecule to fibronectin of these type III repeats.

footnote

The Chile 2010 earthquake had apparently sent a tsunami straight towards us. Great. About TEN(14) reaching ridiculous proportions in Hawaii.

. One such repeat, the 14th EGFL repeat Ten(14) assumes in two distinctly different conformations characterized by FNL1 fibronectin-like 1 domain, the C-terminal fibrinogen-like [FGL1] globe to Fn type III repeats 12-15 in addition to type III repeats 9-11 bound by alpha5beta1. Fibronectin-like type IIIs microfluidic capillary systems (CSs) model of a tissue-engineered blood vessel.[↩]